MESALAMINE DR, Capsule, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00430075327.

Recall Insight

This FDA Drug action (record #D-912-2014) was formally reported on January 29, 2014, with the manufacturer initiating the action on July 2, 2013. It is classified under Moderate severity (Class II), with a current status of Terminated. Aidapak Services, LLC is listed as the recalling firm, operating out of Vancouver, WA. Federal records indicate 180 Capsules units are affected.

The documented reason for this recall is: Labeling: Label Mixup: MESALAMINE DR, Capsule, 400 mg may have potentially been mislabeled as the following drug: CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg, NDC 11868000901, Pedigree: AD34928_1, EXP: 5/9/2014. Distribution data in the federal record shows the product reached: Repacked drugs were distributed in Arizona, California, Oregon, and Washington.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 5 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 12 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.